YouScript

Join us for the STRIPE Annual Meeting and Consensus Workshop! October 23-25, 2024 | U.S. Pharmacopeia Campus, Rockville, MD We’re excited to introduce our lineup of speakers for this year's event. Each week, we’ll highlight a different expert who will be sharing their insights on pharmacogenomics. This week, we are thrilled to feature Kristine Ashcraft, President at YouScript. Kristine will serve as a moderator for the Clinical Decision Support Consensus Workshop. For more information and to register, visit www.stopadr.org/events. We look forward to seeing you there!

The LATEST Precision Medicine Podcast is out! Episode 62: New Legislation Helps Deliver Appropriate Biomarker Testing to More Cancer Patients When and Where They Need It With more targeted treatments becoming available, disparities could increase if precision medicine stakeholders don’t take action to make sure everyone who is a candidate has access to testing. As such, the American Cancer Society Cancer Action Network (ACS CAN) is leading a legislation effort across the US to expand health insurance coverage of comprehensive biomarker testing. Join host Karan Cushman and guests Hilary Gee Goeckner, MSW (Director of State and Local Campaigns for ACS CAN) and Kristine Ashcraft (Founder of YouScript, Aranscia and member of ACS CAN task force) for a deep dive into the legislation progress, patient stories and how you can get involved. Episode link in the comments! #PrecisionMedicine #healthdisparities #ruralhealthcare #biomarkertesting

Aranscia's Houda Hachad commented on her recent co-authored paper released in The Journal of Molecular Diagnostics, "I am honored that I had the opportunity to serve on this amazing panel! We all gathered as representatives of our diverse international PGx community - from consortia leaders, molecular testing experts, and PGx implementers to streamline DPYD testing for all populations. Our joint consensus recommendation, including an expanded list of variants reported in diverse populations across the globe, is available to all – Let’s put it to use! It is time to follow the steps of great implementers of preemptive DPYD testing, such as Atrium Health (read here: https://lnkd.in/gGu7U6dY), and others, and prevent unnecessary harm and hospitalizations." To read the full paper in JMD Journal, click here: https://lnkd.in/dTxiqyNd

As of today, evidence-based #pharmacogenomics testing is now covered by Medi-Cal (AB425) and commercial insurers (SB496) in the state of #California, aligning with Medicare coverage in place since 2020. After years of work, I want to stop and celebrate this win that will help curb the annual loss of 33,000 lives and 62 billion dollar spend due to non-optimized medications in the state. This would not have happened without the leadership of Assemblymember Alvarez, the tireless efforts of his legislative assistant Cynthia Yepez, and countless meetings with other California legislators coordinated by Chantelle Schenning, PhD, MHA, Megan Boyd, MA, CAPM and Michael Hawkins. This would not have happened without outreach to Alvarez by a brave young girl and her Mother looking to improve access for others when #pgx testing resulted in resolution of her #depression symptoms after numerous failed medications. This would not have happened without live testimony from Christine Von Raesfeld 💜on the impact pharmacogenomic testing had in improving her quality of life or Bani Tamraz, Pharm.D., Ph.D. on the science and clinical and financial benefits of testing. This would not have happened without companies and individuals reaching out to their legislators to voice their support for the legislation. I am grateful that so many more patients can now access personalized care, but the work is not over until similar efforts move forward in every state and nationally. Please see where your state stands in moving biomarker legislation forward and join the efforts if needed - https://lnkd.in/gwgcHA8Q. And support national efforts to reduce adverse drug events by asking your Congressional representatives to support the Right Drug Dose Now Act of 2024 - https://lnkd.in/dAf--N7p.

Join us for a free webinar where Kristine Ashcraft, President and Founder of YouScript, will explore the easy process of incorporating #pharmacogenomics into your facility to deliver personalized care for your patients. She'll discuss: ❔ Which patients are ideal candidates ❔ How to begin testing ❔ How to take action on your patient's genomic results Save your spot by registering on Zoom: https://lnkd.in/gybKWnHJ #Pharmacogenomics #PGx #BestPractice #Genomics

We are excited to announce our innovative partnership with Signature RX to develop novel biomarkers and personalized medication management solutions for the effective use of GLP-1 medications. Read the full press release to learn more about this multi-phase partnership and how the program aims to bring a comprehensive, personalized approach to GLP-1s: https://lnkd.in/gVj647wQ #ObesityMedicine #GLP1 #PrecisionMedicine #NovelBiomarkers #WeightLossMedicine #DiabetesMedicine